Conditions: Alzheimer Disease Amyloid Beta-Protein
Keywords: Florbetaben Amyloid beta-protein MCI Alzheimer's disease
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 45
Healthy volunteers: no

Brief summary:
The aim of the study is to investigate whether Florbetaben (BAY94-9172)positron emission tomography (PET) is able to distinguish between subjects with mild cognitive impairment (MCI) progressing to Alzheimer's disease (AD) from those with MCI not progressing to AD.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Florbetaben (BAY94-9172)
Intervention descriptions: intervention 1: single 300 megabecquerel (MBq) intravenous injection 2 mL to 10 mL, at baseline, at 12 and 24 months

Protocol document: